Modular's unique gene engineering system provides a significant competitive advantage by speeding the rate of product development, reducing costs, and allowing many products to be developed simultaneously.
Modular is focused on sustainable chemistry and is a leading company in today's Industrial Biotechnology Revolution. Modular's specialty is the design and development of engineered microorganisms that synthesize biochemicals using cheap renewable raw materials, like sugar. The company also develops fermentation processes, and processes for purifying biochemicals—downstream processing (DSP).
Modular's proprietary automated technology enables rapid engineering of valuable products and gene variants.
Our patented protein optimization platforms are used to identify and assemble proteins for product discovery.
Modular's platform enables the ability to identify and develop new gene traits and properties.
Modular Genetics, Inc. is a privately held growth-stage biotechnology company developing products via automated gene engineering. We are a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are environmentally friendly.
Investors are funding the launch of Modular's first commercial product – a patented acyl amino acid surfactant called AminoSurf-E. This surfactant is a drop-in replacement for cocoyl glutamate, a surfactant manufactured from palm kernel oil. AminoSurf-E is produced by fermentation of sugar. No oil of any sort is used to manufacture AminoSurf-E. Modular's advanced bio-engineering technology positions the company to launch new biochemical products on an ongoing basis. Modular's demonstrated ability to design, develop, and launch new commercial products is positioning the company for an attractive exit.
CEO
Dr. Kevin Jarrell is a co-founder and CEO of Modular Genetics. He developed one of the first commercial automated systems for engineering genes, proteins, and microorganisms. He is an inventor on over 30 patents, including patents protecting Modular’s bioengineering process, and composition-of-matter patents protecting Modular’s products. Dr. Jarrell is a former member of the National Biodefense Science Board, and is an active member of the Alternative Fuels & Chemicals Coalition Advisory Board.
Co-Founder
Dr. Temple Smith, co-founder of Modular Genetics, is recognized as one of the originators of the field of bioinformatics. He is the co-author of the Smith-Waterman algorithm, which is the basis for nearly all genetic sequence comparative analyses. In addition to being one of the original organizers of GenBank, he also established the first bioinformatics research support group at the Dana-Farber Cancer Institute and the Harvard University School of Public Health. Dr. Smith has published over one hundred papers on genetic analyses, disease evolution and protein domain structure. Dr. Smith was formerly a full professor at Boston University and the Director of the University's BioMolecular Engineering Research Center (BMERC).
Mailing Address:
134 Coolidge Ave #2
Watertown, MA 02472
info@modulargenetics.com
Modular Genetics